Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients
NCT02184299 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138
Last updated 2014-07-14
Summary
Study to determine the incidence of rash between the group receiving nevirapine without prednisone and the group receiving nevirapine with prednisone
Conditions
- HIV Infections
Interventions
- DRUG
-
Nevirapine
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-04-30
- Primary Completion
- 2000-01-31
More Related Trials
-
VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients
NCT00561925 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3
NCT00000747 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients
NCT00543803 ·Status: COMPLETED
-
Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS
NCT02191215 ·Status: COMPLETED
-
Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients
NCT00819052 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients
NCT02184078 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
NCT00000859 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell
NCT00002323 ·Status: COMPLETED ·Phase: NA
-
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
NCT00905489 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
NCT00002381 ·Status: COMPLETED ·Phase: PHASE1
-
Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
NCT00199979 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients
NCT02181946 ·Status: COMPLETED ·Phase: PHASE4
-
Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune
NCT00979420 ·Status: COMPLETED
-
An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
NCT00002194 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
NCT00000649 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Dose BE Study With Nevirapine 400mg PR Tablets
NCT02202005 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice
NCT01524900 ·Status: COMPLETED
-
The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients
NCT00001082 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients
NCT00000699 ·Status: COMPLETED ·Phase: PHASE1
-
Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients
NCT00876733 ·Status: COMPLETED
-
A Study to Compare Two Different Anti-HIV Drug Regimens
NCT00000924 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
NCT00000634 ·Status: COMPLETED ·Phase: NA
-
Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
NCT00006494 ·Status: COMPLETED
-
A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
NCT00000914 ·Status: COMPLETED ·Phase: NA
-
Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects
NCT02194179 ·Status: COMPLETED ·Phase: PHASE1